We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Synesthesia Family Exomes Lead to Rare Gene Variants

By LabMedica International staff writers
Posted on 22 Mar 2018
Synesthesia is a neurological phenomenon that causes unusual links between sensory experiences, and its molecular basis is completely unknown. More...
Synesthesia is a perceptual phenomenon in which stimulation of one sensory or cognitive pathway leads to automatic, involuntary experiences in a second sensory or cognitive pathway.

In many cases, color sensations are triggered by specific cues such as the sight of letters, numbers, or words, though other sensory stimuli and secondary perceptions may be linked. While past studies hinted that enhanced brain neuronal connectivity contributes to such processes, the genetic basis of these interconnections remains murkier.

An international team of scientists led by those at the Max Planck Institute for Psycholinguistics (Nijmegen, The Netherlands) identified three multi-generation families affected with auditory-visual synesthesia that linked sounds to color. To explore these pathways in one type of synesthesia, the team performed whole-exome sequencing on several affected and unaffected family members in three auditory-visual synesthesia-affected pedigrees spanning at least three generations. From nearly 11,600 suspicious variants in the families, they narrowed in on 3,864 rare variants for additional analyses.

The team further focused in on 37 rare, heterozygous mutations that tracked with synesthesia in the families and followed a dominant inheritance pattern. Although the same variants were not found across families, three of the variants were previously linked to synesthesia in autism spectrum disorder-affected families profiled. DNA was extracted from blood, buccal swabs, or Oragene kits of 18 individuals from the three selected synesthesia families. Library preparation began with 3 μg of purified DNA. Enrichment for exonic regions was performed using the SOLiD-optimized Sure Select All Human Exon Kit followed by sequencing on 5500XL Genetic Analysis System.

Consistent with reports indicating genetic heterogeneity, no variants were shared across families. Gene ontology analyses highlighted six genes: COL4A1, ITGA2, MYO10, ROBO3, SLC9A6, and SLIT2, associated with axonogenesis and expressed during early childhood when synesthetic associations are formed. Available gene- and protein expression data indicated that these genes are expressed in the human brain, particularly during development and childhood, while the investigator’s own array-based tests on six post-mortem brain samples supported the notion that the genes are expressed in parts of the brain previously implicated in synesthesia.

Amanda Katherine Tilot, PhD, the lead author of the study, said, “Brain imaging of adults with synesthesia suggests that their circuits are wired a little differently compared to people who don't make these extra sensory associations. What we don't know yet is how these differences develop. We suspect some of the answers lie in people's genetic makeup.” The study was published on March 5, 2018 in the journal Proceedings of the National Academy of Sciences.

Related Links:
Max Planck Institute for Psycholinguistics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.